Form 4 for HUMA Humacyte, Inc.
Accepted 2024-08-29 00:00:00 ET · period of report 2024-08-27 · accession 0001818382-24-000165 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-08-29 | 2024-08-27 | HUMA | Sander Dale A. | CFO, Chief Corp. Deve. Off | S - Sale+OE | $6.68 | -39.4K | 2,000 | -95% | -$263.1K |
| D | 2024-08-29 | 2024-08-27 | HUMA | Sander Dale A. | CFO, Chief Corp. Deve. Off | M - OptEx | $2.56 | +39.4K | 41.4K | +1,969% | +$100.8K |
| D | 2024-08-29 | 2024-08-27 | HUMA | Sander Dale A. | CFO, Chief Corp. Deve. Off | M - OptEx | $0.00 | -39.4K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-27 | S | D | 39,389 | $6.68 | 2,000 | D | — | — | (F1) The price is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $6.67 to $6.725. The Reporting Person undertakes to provide upon request to the SEC staff, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2024-08-27 | M | A | 39,389 | $2.56 | 41,389 | D | — | — | |
| 3 | Derivative | Stock Options (right to buy) | 2024-08-27 | M | D | 39,389 | $0.00 | 0 | D | $2.56 · 2018-09-01 to 2025-09-01 | 39,389 Common Stock |